Moderate hypertension: treatment with guanethidine and methyldopa
Dunn, M.I.; Freeman, J.
Current Therapeutic Research 18(2): 285-294
1975
ISSN/ISBN: 0011-393X PMID: 809241 Document Number: 83406
Document emailed within 1 workday
Related Documents
Tarpley, E.L. 1974: Controlled trial of guanethidine and methyldopa in moderate hypertension Current Therapeutic Research 16(11): 1187-1196Agarwal, R.K.; Bhatnagar, M.K.; Shukla, S.K.; Gupta, R.; Dwivedi, R.N. 1980: Methyldopa and propranolol in moderate hypertension Indian Heart Journal 32(1): 13-15
Zicot, M. 1980: Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine Revue Medicale de Liege 35(19): 652-654
Rosendorff, C. 1982: Guanabenz versus methyldopa in the therapy of mild-to-moderate hypertension South African Medical Journal 62(13): 435-437
Rankin, G.O.; Watkins, B.E.; Sawutz, D.G. 1982: Chlorpromazine interactions with guanethidine and alpha-methyldopa: effects on arterial pressure control and heart rate in renovascular hypertensive rats Archives Internationales de Pharmacodynamie et de Therapie 260(1): 130-140
Caldwell, J.R.; Metts, J.C. 1981: Long-term treatment of hypertension with methyldopa. III. Tolerability Journal of Cardiovascular Pharmacology 3(Suppl 2): S92-S98
Bolzano, K.; Krempler, F.; Sandhofer, F. 1984: A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension Acta Medica Austriaca 11(2): 49-53
Seedat, Y.K.; Vawda, E.I.; Mitha, S.; Ramasar, R. 1970: A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension South African Medical Journal 44(10): 300-301
Itskovitz, H.D.; Menduke, H. 1981: Long-term treatment of hypertension with methyldopa. I. Study objectives and design Journal of Cardiovascular Pharmacology 3(Suppl 2): S79-S84
Plouin, P.F.; Bréart, G.; Maillard, F.; Papiernik, E.; Relier, J.P. 1987: Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial Archives des Maladies du Coeur et des Vaisseaux 80(6): 952-955
Webb, C.E.; Elliston, E.B. 1976: Guanethidine therapy of hypertension Journal of Family Practice 3(4): 348
Dallocchio, M.; Clémenty, J. 1979: Moderate arterial hypertension: what treatment Annales de Cardiologie et d'Angeiologie 28(1): 41-45
Tomov, I. 1986: New trends in the treatment of moderate arterial hypertension Vutreshni Bolesti 25(1): 7-16
Voges, D.; Fryda-Kaurimsky, Z. 1978: Treatment of mild and moderate hypertension with viskaldix Schweizerische Rundschau für Medizin Praxis 67(42): 1554-1557
Kaul, U.A.; Chutani, S.K.; Verma, I.C.; Khalilullah, M. 1989: Captopril in the treatment of moderate to severe hypertension Journal of the Association of Physicians of India 37(2): 152-154
Amabile, G.; Hulin, P.; Wajman, A.; Serradimigni, A.; Bory, M. 1989: Slow-release verapamil 240 mg and treatment of mild to moderate hypertension Therapie 44(4): 275-278
Madonna, O.; Labeeuw, M.; Pozet, N.; Aissa, A.H.; Zech, P. 1988: Influence of treatment by betaxolol on the renal response to postural changes in moderate hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 26(3): 133-137
Pessina, A.C. 1995: Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study La Clinica Terapeutica 146(1): 3-12
Walker, R.G.; Whitworth, J.A.; Saines, D.; Kincaid-Smith, P. 1981: Prazosin. Long-term treatment of moderate and severe hypertension and lack of "tolerance" Medical Journal of Australia 2(3): 146-147
Sauerbrey-Wullkopf, N.; Anlauf, M. 1995: Amlodipine in long-term treatment of mild and moderate hypertension. a multicenter study Fortschritte der Medizin 113(5): 58-62